Antiplatelet drugs, anticoagulants and elective surgery

Australian Prescriber

Volumn 34, Issue 5, 2011, Pages 139-143

  Merriman, Eileen ^a   Tran, Huyen ^b  

^a MONASH MEDICAL CENTRE   (Australia)

^b MONASH UNIVERSITY   (Australia)

Author keywords

Aspirin; Clopidogrel; Heparin; Warfarin

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; CLOPIDOGREL; DABIGATRAN; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; RIVAROXABAN; WARFARIN;

ARTERY THROMBOSIS; ARTICLE; BLEEDING DISORDER; BLOOD TRANSFUSION; CARDIOLOGIST; CONSULTATION; CORONARY STENT; DENTAL SURGERY; DERMATOLOGICAL PROCEDURES; DRUG SUBSTITUTION; DRUG WITHDRAWAL; ELECTIVE SURGERY; EPIDURAL ANESTHESIA; EYE SURGERY; HEART ATRIUM FIBRILLATION; HEART SURGERY; HUMAN; POSTOPERATIVE HEMORRHAGE; POSTOPERATIVE THROMBOSIS; RISK BENEFIT ANALYSIS; SPINAL ANESTHESIA; SURGICAL RISK; UNSPECIFIED SIDE EFFECT; VENOUS THROMBOEMBOLISM;

EID: 80053925495     PISSN: 03128008     EISSN: None     Source Type: Journal    
DOI: 10.18773/austprescr.2011.074     Document Type: Article

References (13)

1. Merritt JC, Bhatt DL. The efficacy and safety of perioperative antiplatelet therapy. J Thromb Thrombolysis 2004;17:21-7.
2. Mangano DT; Multicenter Study of Perioperative Ischemia Research Group. Aspirin and mortality from coronary bypass surgery. N Engl J Med 2002;347:1309-17.
3. Yende S, Wunderink RG. Effect of clopidogrel on bleeding after coronary artery bypass surgery. Crit Care Med 2001;29:2271-5.
4. Fitchett D, Eikelboom J, Fremes S, Mazer D, Singh S, Bittira B, et al. Dual antiplatelet therapy in patients requiring urgent coronary artery bypass grafting surgery: a position statement of the Canadian Cardiovascular Society. Can J Cardiol 2009;25:683-9.
5. Douketis JD, Berger PB, Dunn AS, Jaffer AK, Spyropoulos AC, Becker RC, et al. The perioperative management of antithrombotic therapy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 2008;133(6 Suppl):299S-339S.
6. O'Donnell MJ, Kearon C, Johnson J, Robinson M, Zondag M, Turpie I, et al. Brief communication: Preoperative anticoagulant activity after bridging low-molecular-weight heparin for temporary interruption of warfarin. Ann Intern Med 2007;146:184-7.
7. Spyropoulos AC, Turpie AG, Dunn AS, Spandorfer J, Douketis J, Jacobson A, et al. Clinical outcomes with unfractionated heparin or low-molecular-weight heparin as bridging therapy in patients on long-term oral anticoagulants: the REGIMEN registry. J Thromb Haemost 2006;4:1246-52.
8. Dunn AS, Spyropoulos AC, Turpie AG. Bridging therapy in patients on long-term oral anticoagulants who require surgery: the Prospective Peri-operative Enoxaparin Cohort Trial (PROSPECT). J Thromb Haemost 2007;5:2211-8.
9. Douketis JD. Perioperative management of patients who are receiving warfarin therapy: an evidence-based and practical approach. Blood 2011;117:5044-9.
10. Sacco R, Sacco M, Carpenedo M, Moia M. Oral surgery in patients on oral anticoagulant therapy: a randomized comparison of different INR targets. J Thromb Haemost 2006;4:688-9.
11. Al-Mubarak S, Rass MA, Alsuwyed A, Alabdulaaly A, Ciancio S. Thromboembolic risk and bleeding in patients maintaining or stopping oral anticoagulant therapy during dental extraction. J Thromb Haemost 2006;4:689-91.
12. Weitz JI. New oral anticoagulants in development. Thromb Haemost 2010;103:62-70.
13. Gage BF, Waterman AD, Shannon W, Boechler M, Rich MW, Radford MJ. Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation. JAMA 2001;285:2864-70.